Status:
COMPLETED
Electrical Stimulation for Critically Ill Post-Covid-19 Patients
Lead Sponsor:
Baylor College of Medicine
Collaborating Sponsors:
Avazzia, Inc
Conditions:
COVID-19
Muscle Atrophy
Eligibility:
All Genders
18-100 years
Phase:
PHASE2
Brief Summary
Unfortunately, hospital-acquired weakness is highly prevalent among COVID-19 hospitalized patients, who often require prolonged bed-rest or paralytics for an extended period of time in order to mainta...
Detailed Description
20 subjects that were hospitalized due to severe COVID-19 infection and present neuromuscular complications (i.e., hospital acquired weakness due to neuromyopathy) will be recruited after the first ph...
Eligibility Criteria
Inclusion
- Post-COVID-19 patients who required hospitalization due to COVID-19 severe infection.
- Post-COVID-19 patients who required hospitalization and present neuromuscular sequelae due to COVID-19 severe infection.
Exclusion
- Patient has a demand-type cardiac pacemaker, implanted defibrillator or other implanted electronic device.
- Active wound infection.
- Below the knee amputations.
- Based on the clinicians decision whether the patient is eligible for the study.
Key Trial Info
Start Date :
August 18 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 18 2022
Estimated Enrollment :
19 Patients enrolled
Trial Details
Trial ID
NCT05198466
Start Date
August 18 2021
End Date
August 18 2022
Last Update
March 7 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Baylor College of Medicine
Houston, Texas, United States, 77030